Capricor Therapeutics, Inc

(NASDAQ:CAPR)

Latest On Capricor Therapeutics, Inc (CAPR):

Date/Time Type Description Signal Details
2023-05-12 07:12 ESTNewsCapricor Therapeutics, Inc. (CAPR) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 17:36 ESTNewsCapricor Therapeutics GAAP EPS of -$0.31 beats by $0.01, revenue of $2.98M beats by $2.48MN/A
2023-03-16 00:26 ESTNewsCapricor Therapeutics GAAP EPS of -$0.31 beats by $0.03, revenue of $0.96M beats by $0.96MN/A
2023-03-16 00:26 ESTNewsCapricor Therapeutics, Inc. (CAPR) Q4 2022 Earnings Call TranscriptN/A
2023-03-14 18:00 ESTNewsCapricor Therapeutics Q4 2022 Earnings PreviewN/A
2023-01-25 14:41 ESTNewsCapricor stock falls amid data for duchenne muscular dystrophy studyN/A
2022-11-11 07:18 ESTNewsCapricor Therapeutics GAAP EPS of -$0.26 beats by $0.05, revenue of $1.59M beats by $1.45MN/A
2022-11-11 07:17 ESTNewsCapricor Therapeutics, Inc. (CAPR) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 21:36 ESTNewsCapricor Therapeutics Q3 2022 Earnings PreviewN/A
2022-08-12 00:03 ESTNewsCapricor stock rises 16% after update on muscular dystrophy treatment, Q2 resultsN/A
2022-08-11 07:06 ESTNewsCapricor Therapeutics GAAP EPS of -$0.29 misses by $0.03N/A
2022-08-11 07:06 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2022 Results Earnings Call TranscriptN/A
2022-08-09 20:06 ESTNewsCapricor Therapeutics Q2 Earnings PreviewN/A
2022-06-28 01:00 ESTNewsCapricor posts statistically significant data for DMD candidate in open-label trialN/A
2022-05-11 01:15 ESTNewsCapricor Therapeutics GAAP EPS of -$0.32N/A
2022-05-11 01:15 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marban on Q1 2022 Results - Earnings Call TranscriptN/A
2022-03-28 16:40 ESTNewsCapricor Therapeutics down 24% following COVID-19 mid-stage trial results (updated)N/A
2022-03-11 08:26 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marban On Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-25 10:04 ESTNewsCapricor jumps 12% after CAP-1002 commercialization deal in U.S. for treatment of DMDN/A
2021-12-13 16:39 ESTNewsCapricor Therapeutics provides key updates on its COVID-19 vaccine programsN/A
2021-11-10 04:09 ESTNewsCapricor Therapeutics EPS beats by $0.06N/A
2021-11-10 04:08 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 05:10 ESTNewsCapricor Therapeutics Q3 2021 Earnings PreviewN/A
2021-09-25 19:24 ESTNewsCapricor Therapeutics Announces Another 'Final' 12-Month P2 Duchenne Muscular Dystrophy Trial ResultN/A
2021-09-24 23:37 ESTNewsCapricor jumps 17% on positive CAP-1002 data from mid-stage duchenne muscular dystrophy studyN/A
2021-09-02 16:11 ESTNewsCapricor shares up 6 % as it will present final data on muscular dystrophy candidate late SeptemberN/A
2021-08-13 10:16 ESTNewsCapricor Therapeutics EPS beats by $0.02, misses on revenueN/A
2021-08-13 10:15 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-20 22:51 ESTNewsCapricor Therapeutics slumps 9% on $75M stock offeringN/A
2021-04-30 07:24 ESTNewsCapricor shares rise on license agreement with Johns Hopkins UniversityN/A
2021-03-18 04:19 ESTFinancialsCompany financials have been released.Neutral
2021-03-13 03:16 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 07:18 ESTEarnings EstimateAn EPS average of -$1.07 is estimated for the 2022 year.Sell
2021-03-12 00:43 ESTNewsCapricor Therapeutics EPS misses by $0.01N/A
2021-03-12 00:43 ESTNewsCapricor Therapeutics' (CAPR) CEO Linda Marbán on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-09 13:49 ESTNewsCapricor Therapeutics updates on COVID-19 vaccine pre-clinical studyN/A
2021-02-10 08:09 ESTNewsCapricor Therapeutics - Shockingly Undervalued With Imminent Catalysts In PlayN/A
2021-02-01 10:47 ESTNewsCapricor signs intellectual property license for COVID-19 serology test platformN/A
2021-01-25 03:17 ESTAnalyst RatingThe Analyst Target Price has increased from $10.5 to $12.Buy
2021-01-20 01:02 ESTNewsCapricor announces positive findings from collaboration with Cedars-Sinai Medical Center researchersN/A
2021-01-12 20:54 ESTNewsCapricor and Lonza tie up in DMD developmentN/A
2020-12-13 03:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 15:54 ESTNewsDosing underway in Capricor Therapeutics' mid-stage CAP-1002 study in COVID-19N/A
2020-11-18 03:20 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:25 ESTFinancialsCompany financials have been released.Neutral
2020-11-15 11:31 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 03:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 22:56 ESTNewsCapricor Therapeutics, Inc's (CAPR) CEO Linda Marbán on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-12 19:06 ESTNewsCapricor Therapeutics reports Q3 resultsN/A
2020-11-01 17:26 ESTFinancialsCompany financials have been released.Neutral

About Capricor Therapeutics, Inc (CAPR):

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy (DMD), and other rare disorders. The company's development stage drug candidates for cardiosphere-derived cells include CAP-1002, a cardiac cell derived therapy, which is in phase II clinical trial for the treatment of patients with late-stage DMD; and completed various trials investigating the use of CAP-1002 for the treatment of cardiac conditions, including heart failure and post myocardial infarction with cardiac dysfunction. It is also developing CAP-2003 that is in pre-clinical development for the treatment of inflammatory conditions. Capricor collaborates with Lonza for the development of CAP-1002, its cell therapy candidate for the treatment of Duchenne muscular dystrophy and other indications. The company was founded in 2005 and is headquartered in Beverly Hills, California.

CAPR Quotes by TradingView

See Advanced Chart

General

  • Name Capricor Therapeutics, Inc
  • Symbol CAPR
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Last Split Factor1:10
  • Last Split Date2019-06-05
  • Fiscal Year EndDecember
  • IPO Date2007-02-13
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.capricor.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 149.52
  • Price/Book (Most Recent Quarter) 4.13
  • Enterprise Value Revenue 190.86
  • Enterprise Value EBITDA 0.03
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.00
  • Next Year EPS Estimate -$1.06
  • Operating Margin -4413%
  • Return on Assets -37%
  • Return on Equity -78%
  • Revenue 310250
  • Earnings Per Share -$3.74
  • Revenue Per Share $0.02
  • Gross Profit -8146750
  • Quarterly Earnings Growth -74%
View More

Highlights

  • Market Capitalization 118.78 million
  • EBITDA -11929662
  • Analyst Target Price $12
  • Book Value Per Share $1.37
View More

Share Statistics

  • Shares Outstanding 22.8 million
  • Shares Float 19.99 million
  • % Held by Insiders 253%
  • % Held by Institutions 6.2%
  • Shares Short 345150
  • Shares Short Prior Month 489136
  • Short Ratio 0.36
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 6.47
  • 52 Week High $12.32
  • 52 Week Low $0.96
  • 50 Day Moving Average 6.37
  • 200 Day Moving Average 5.05
View More

Dividends

  • Dividend Date 2019-06-05
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Capricor Therapeutics, Inc (CAPR) Dividend Calendar:

CAPR's last dividend payment was made to shareholders on June 5, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Capricor Therapeutics, Inc (CAPR) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$N/A-$0.21-$0.20-5%
2020-09-302020-11-12$N/A-$0.20-$0.3745.95%
2020-06-302020-08-06$N/A-$0.23-$0.3432.35%
2020-03-312020-05-13$185693-$0.30-$0.3616.67%
2019-12-312020-03-18$222100-$0.34-$0.340%
2019-09-302019-11-07$142071-$0.43-$0.6836.76%
2019-06-302019-08-06$410353-$0.59-$0.8026.25%
2019-03-312019-05-13$230504-$0.80-$1.1027.27%
2018-12-312019-03-28$648082-$1.10-$1.6031.25%
2018-09-302018-11-13$219247-$1.40-$1.453.45%
2018-06-302018-08-09$403960-$1.40-$1.25-12%
2018-03-312018-05-10$400066-$1.40-$1.20-16.67%
2017-12-312018-03-14$475000$4.20-$1.00520%
2017-09-302017-11-08$314000-$1.20-$1.9036.84%
2017-06-302017-08-10$996000-$1.60-$1.8011.11%
2017-03-312017-05-15$881000-$1.70-$1.50-13.33%
2016-12-312017-03-15$907000-$2.10-$2.7022.22%
2016-09-302016-11-10$747000-$2.90-$2.65-9.43%
2016-06-302016-08-15$1.13 million-$2.60-$2.40-8.33%
2016-03-312016-05-12$1.22 million-$2.60-$1.90-36.84%
2015-12-312016-03-17$1.12 million-$2.10-$1.90-10.53%
2015-09-302015-11-12$1.32 million-$0.18-$0.2630.77%
2015-06-302015-08-13$1.29 million-$0.19-$0.2626.92%
2015-03-312015-05-12$1.79 million-$0.23-$0.14-64.29%
2014-12-312015-03-16$1.4 million-$0.16-$0.13-23.08%
2014-09-302014-11-14$1.3 million-$0.13-$0.2240.91%
2014-06-302014-08-14$1.04 million-$1.31
2014-03-312014-05-15$1.04 million-$1.04
2013-12-312014-03-17$503233-$6.39
2013-09-302013-11-15$80000-$4.02
2013-06-302013-08-15$190000-$6.94
2013-03-312013-06-21$233000-$5.61
2012-12-312013-03-12$2.03 million-$2.39
2012-09-302012-11-12$-2423235-$6.57
2012-06-302012-08-13$N/A-$4.11
2012-03-312012-05-15$195500-$20.00-$15.00-33.33%
2011-12-312012-03-13-$22.29
2011-09-302011-11-14$813000-$15.00-$7.50-100%
2011-06-302011-08-15$346000-$15.00-$5.00-200%
2011-03-312011-05-16-$15.00-$10.00-50%
2010-12-312011-03-14-$10.00-$21.6753.85%
2010-09-302010-11-12-$25.00-$23.33-7.16%
2010-06-302010-08-16-$25.00-$33.3324.99%
2010-03-312010-05-14-$35.00-$28.33-23.54%
2009-12-312010-03-03-$30.00-$25.00-20%
2009-09-302009-11-12-$40.00-$25.00-60%
2009-06-302009-08-13-$50.00-$37.50-33.33%
2009-03-312009-05-14-$35.00-$58.3340%
2008-12-312009-03-09-$60.00-$65.007.69%
2008-09-302008-11-13-$70.00-$78.3310.63%
2008-06-302008-08-14-$80.00-$57.50-39.13%
2008-03-312008-05-15-$65.00-$55.00-18.18%
2007-12-312008-03-13-$50.00-$95.0047.37%
2007-09-302007-11-28-$173.63
2006-12-312006-12-31-$6.69
2006-09-302006-09-30-$23.16
2006-06-302006-06-30-$5.98
2006-03-312006-03-31-$4.79
2005-09-302005-09-30-$2.28
2005-06-302005-06-30-$1.95
2005-03-312005-03-31-$3.57
2004-12-312004-12-31-$6.14
2004-09-302004-09-30-$2.33
2004-06-302004-06-30-$1.90
2004-03-312004-03-31-$1.64
2003-12-312003-12-31-$3.57
2003-09-302003-09-30-$0.06
2003-06-302003-06-30-$4.61
2003-03-312003-03-31-$2.46
2002-12-312002-12-31-$2.50
2002-09-302002-09-30-$5.67
2002-06-302002-06-30-$6.25

Capricor Therapeutics, Inc (CAPR) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A 1.16 million 828749
Income Before Tax N/A N/A N/A -2.08 million -1.47 million
Selling General Administrative N/A N/A N/A 1.14 million 876720
Gross Profit N/A N/A N/A N/A 222100
Ebit N/A N/A N/A -2.07 million -1.48 million
Operating Income N/A N/A N/A -2.11 million -1.48 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A 185693 222100
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A 22690 13951
Net Income From Continuing Operations N/A N/A N/A -2.08 million -1.47 million
Net Income Applicable to Common Shares -4.18 million -3.91 million -3.48 million N/A -1.47 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities N/A N/A 426904 N/A N/A
Total Cash Flow from Investing Activities N/A N/A 5.99 million N/A N/A
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A N/A N/A N/A
Change to Operating Activities N/A N/A 149635 N/A N/A
Change in Cash N/A N/A N/A N/A N/A
Total Cash from Operating Activities N/A N/A -1.22 million N/A N/A
Depreciation N/A N/A N/A N/A N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income N/A N/A 287807 N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A 5.78 million 5.47 million N/A N/A
Total Stockholder Equity N/A 30.41 million 31.65 million N/A N/A
Other Current Liabilities N/A N/A N/A N/A N/A
Total Assets N/A 36.19 million 37.13 million N/A N/A
Common Stock 20577 20212 N/A 9189 N/A
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -88.04 million -83.86 million N/A -76.47 million N/A
Other Liabilities 3.38 million 3.38 million N/A 3.38 million N/A
Other Assets 88701 88701 N/A 107380 N/A
Cash N/A N/A N/A N/A N/A
Total Current Liabilities 2.97 million 2.28 million N/A N/A N/A
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 850847 603719 N/A 410913 N/A
Total Current Assets 33.68 million 35.49 million 36.25 million N/A N/A
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 28.2 million 30.4 million 9.59 million 9.59 million N/A
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 2.72 million 2.06 million N/A N/A N/A

Capricor Therapeutics, Inc (CAPR) Chart:

Capricor Therapeutics, Inc (CAPR) News:

Below you will find a list of latest news for Capricor Therapeutics, Inc (CAPR) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Capricor Therapeutics, Inc (CAPR) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-07-182.57.8CALL100 0371.61TRUE7.80
2025-07-1855.32CALL104 376206.34TRUE0.340.07
2025-07-187.52.9CALL141 963121.16TRUE-0.1-0.03
2025-07-18101.5CALL112 2438124.02TRUE0.20.15
2025-07-1812.50.7CALL25 2851144.48FALSE00
2025-07-18150.35CALL31 1936150.98FALSE00
2025-07-1817.50.28CALL10 1822174.6FALSE0.080.4
2025-07-18200.2CALL0 32191.49FALSE00
2025-07-1822.50.25CALL0 75242.59FALSE00
2025-07-18250.1CALL2 114199.06FALSE0.040.67
2025-07-182.50.03PUT0 104280.32FALSE00
2025-07-1850.08PUT0 266149.04FALSE00
2025-07-187.50.27PUT103 2843134.44FALSE-0.05-0.16
2025-07-18101.4PUT7 1746152.78FALSE00
2025-07-1812.53.27PUT6 1965173.93TRUE-0.73-0.18
2025-07-18155.3PUT25 488172.77TRUE-0.2-0.04
2025-07-1817.58PUT0 36180.22TRUE00
2025-07-182012.8PUT0 50163.94TRUE00
2025-07-1822.50PUT0 0185.58TRUE00
2025-07-18250PUT0 0182.79TRUE00
2025-08-152.50CALL0 0304.05TRUE00
2025-08-1555.64CALL5 33197.54TRUE0.140.03
2025-08-157.53.54CALL3 49146.7TRUE-0.21-0.06
2025-08-15102.4CALL1 2783155.57TRUE-0.12-0.05
2025-08-1512.52.01CALL4 2355173.24FALSE0.060.03
2025-08-15151.5CALL2 2698186.55FALSE0.20.15
2025-08-1517.51CALL3 397178.27FALSE-0.07-0.07
2025-08-15200.85CALL0 95189.76FALSE00
2025-08-1522.50.72CALL0 247190.22FALSE00
2025-08-15250.5CALL3 3645187.87FALSE-0.11-0.18
2025-08-152.50.05PUT5 560209.26FALSE0.050
2025-08-1550.4PUT30 5162192.21FALSE-0.05-0.11
2025-08-157.51.4PUT285 6245200.32FALSE-0.15-0.1
2025-08-15102.7PUT19 5945193.35FALSE-0.15-0.05
2025-08-1512.54.46PUT5 1663196.75TRUE-0.14-0.03
2025-08-15156.95PUT0 404210.27TRUE00
2025-08-1517.510.6PUT0 1204.31TRUE00
2025-08-152010.2PUT0 11208.48TRUE00
2025-08-1522.50PUT0 0223.19TRUE00
2025-08-152517.6PUT0 2209.74TRUE00
2025-09-192.56.68CALL0 3217.09TRUE00
2025-09-1954.03CALL0 98224.17TRUE00
2025-09-197.55.4CALL75 6004243.45TRUE0.60.13
2025-09-19104.7CALL40 2195250.33TRUE0.10.02
2025-09-1912.53.95CALL196 2771242.93FALSE-0.1-0.02
2025-09-19153.5CALL17 7221245.66FALSE-0.1-0.03
2025-09-1917.52.92CALL1 465236.73FALSE0.170.06
2025-09-19202.5CALL8 4780232.55FALSE-0.02-0.01
2025-09-1922.52.1CALL0 306221.23FALSE00
2025-09-19251.38CALL0 3402216.27FALSE00
2025-09-19301.25CALL106 2036212.25FALSE0.250.25
2025-09-192.50.35PUT233 6280257.41FALSE00
2025-09-1951.53PUT228 4138272.06FALSE-0.09-0.06
2025-09-197.53.25PUT34 10906288.53FALSE-0.05-0.02
2025-09-19104.9PUT15 2930279.87FALSE-0.2-0.04
2025-09-1912.56.95PUT196 2334287.97TRUE6.950
2025-09-19159PUT1 631289.18TRUE90
2025-09-1917.510.05PUT0 70262.49TRUE00
2025-09-192012.5PUT0 75262.38TRUE00
2025-09-1922.50PUT0 8259.67TRUE00
2025-09-192516.3PUT0 16252.28TRUE00
2025-09-193018.7PUT0 1250.36TRUE00
2025-12-192.56.2CALL0 8146.06TRUE00
2025-12-1955.3CALL0 2223164.62TRUE00
2025-12-197.54.9CALL0 2569177.93TRUE00
2025-12-19105CALL0 5870190.24TRUE00
2025-12-1912.53.5CALL0 913179.36FALSE00
2025-12-19153.5CALL0 1330180.74FALSE00
2025-12-1917.52.7CALL0 4614174.39FALSE00
2025-12-19202.4CALL0 642173.92FALSE00
2025-12-1922.53CALL0 3168.91FALSE00
2025-12-19252.1CALL2 314164.99FALSE0.010
2025-12-192.50.6PUT0 363211.72FALSE00
2025-12-1951.95PUT3 1800222.56FALSE0.10.05
2025-12-197.53.6PUT2 62222.7FALSE-0.05-0.01
2025-12-19105.3PUT2 4724216.19FALSE-0.1-0.02
2025-12-1912.57.8PUT0 271203.74TRUE00
2025-12-19159.46PUT0 21201.18TRUE00
2025-12-1917.510.05PUT0 507205.39TRUE00
2025-12-19200PUT0 0201.77TRUE00
2025-12-1922.50PUT0 0198.42TRUE00
2025-12-19250PUT0 0197.37TRUE00
2026-01-162.57.6CALL0 28153.31TRUE00
2026-01-1654.65CALL0 175155.84TRUE00
2026-01-167.55.1CALL0 4350157.65TRUE00
2026-01-16105.2CALL0 2500178.5TRUE00
2026-01-1612.52.91CALL0 404166.31FALSE00
2026-01-16153.3CALL0 1088158.98FALSE00
2026-01-1617.52.9CALL0 110165.09FALSE00
2026-01-16202.4CALL0 149167.92FALSE00
2026-01-1622.50CALL0 331160.8FALSE00
2026-01-16252.3CALL3 92159.72FALSE00
2026-01-16301.81CALL1 4357150.65FALSE1.810
2026-01-162.50.65PUT0 329252.1FALSE00
2026-01-1652.45PUT0 196194.85FALSE00
2026-01-167.53.6PUT0 681210.17FALSE00
2026-01-16105.55PUT0 1347208.27FALSE00
2026-01-1612.58.37PUT0 1718201.89TRUE00
2026-01-16150PUT0 258198.78TRUE00
2026-01-1617.50PUT0 197197.08TRUE00
2026-01-16200PUT0 251195.35TRUE00
2026-01-1622.50PUT0 0192.21TRUE00
2026-01-16250PUT0 0192.96TRUE00
2026-01-163020.9PUT0 48188.24TRUE00
2027-01-152.56.59CALL0 7489.52TRUE00
2027-01-1555.85CALL0 722114.93TRUE00
2027-01-157.56.14CALL4 2625112.18TRUE0.340.06
2027-01-15105.2CALL7 675105.67TRUE5.20
2027-01-1512.54CALL0 494119.37FALSE00
2027-01-15154CALL0 226114.44FALSE00
2027-01-1517.54CALL0 1147117.1FALSE00
2027-01-15203CALL0 134102.19FALSE00
2027-01-1522.52.7CALL0 27100.94FALSE00
2027-01-15252.9CALL3 783105.82FALSE-0.2-0.06
2027-01-15302.46CALL0 857105.93FALSE00
2027-01-152.51.07PUT0 55152.86FALSE00
2027-01-1552.8PUT2 65169.31FALSE0.40.17
2027-01-157.54.4PUT2 32158.05FALSE00
2027-01-15106.74PUT0 110148.67FALSE00
2027-01-1512.57.6PUT0 149146.08TRUE00
2027-01-15150PUT0 14155.07TRUE00
2027-01-1517.511.46PUT0 1148.22TRUE00
2027-01-152014PUT0 54144.65TRUE00
2027-01-1522.50PUT0 0148.41TRUE00
2027-01-15250PUT0 0145.95TRUE00
2027-01-153021.35PUT0 11145.98TRUE00

Latest CAPR Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST62$3.88
Jun 13, 2022 7:58 PM EST5$3.8
Jun 13, 2022 7:59 PM EST100$3.8
Jun 13, 2022 7:59 PM EST100$3.79
Jun 13, 2022 7:59 PM EST50$3.79

Capricor Therapeutics, Inc (CAPR) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920074227/0001104659-20-074227-index.htm
2018-10-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133869/000000000018034036/0000000000-18-034036-index.htm
2019-12-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133869/000000000019016215/0000000000-19-016215-index.htm
2020-05-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133869/000000000020004293/0000000000-20-004293-index.htm
2019-12-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133869/000091957419007837/0000919574-19-007837-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919061080/0001104659-19-061080-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000110465919061773/0001104659-19-061773-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919063785/0001104659-19-063785-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919064252/0001104659-19-064252-index.htm
2019-12-05S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465919070066/0001104659-19-070066-index.htm
2019-12-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465919072396/0001104659-19-072396-index.htm
2019-12-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465919072626/0001104659-19-072626-index.htm
2019-12-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133869/000110465919072629/0001104659-19-072629-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919073161/0001104659-19-073161-index.htm
2019-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919073600/0001104659-19-073600-index.htm
2019-12-19424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1133869/000110465919074049/0001104659-19-074049-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074247/0001104659-19-074247-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074513/0001104659-19-074513-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074514/0001104659-19-074514-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074516/0001104659-19-074516-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022098/0001104659-20-022098-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/0001104659-20-022099-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/0001104659-20-022100-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022101/0001104659-20-022101-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022102/0001104659-20-022102-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022103/0001104659-20-022103-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022104/0001104659-20-022104-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022105/0001104659-20-022105-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022110/0001104659-20-022110-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920031538/0001104659-20-031538-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920034994/0001104659-20-034994-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920035320/0001104659-20-035320-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920038468/0001104659-20-038468-index.htm
2020-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000110465920039272/0001104659-20-039272-index.htm
2020-04-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920047790/0001104659-20-047790-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920056292/0001104659-20-056292-index.htm
2020-05-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920056303/0001104659-20-056303-index.htm
2020-05-07S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465920058189/0001104659-20-058189-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920058192/0001104659-20-058192-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920060449/0001104659-20-060449-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920060930/0001104659-20-060930-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920061570/0001104659-20-061570-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920062419/0001104659-20-062419-index.htm
2020-05-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133869/000110465920062458/0001104659-20-062458-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920062698/0001104659-20-062698-index.htm
2020-05-19424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920063822/0001104659-20-063822-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920066994/0001104659-20-066994-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071410/0001104659-20-071410-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071413/0001104659-20-071413-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071415/0001104659-20-071415-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071417/0001104659-20-071417-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071419/0001104659-20-071419-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071420/0001104659-20-071420-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071421/0001104659-20-071421-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071423/0001104659-20-071423-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071426/0001104659-20-071426-index.htm
2020-06-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920074227/0001104659-20-074227-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920087909/0001104659-20-087909-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920091413/0001104659-20-091413-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920092415/0001104659-20-092415-index.htm
2020-08-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920098381/0001104659-20-098381-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920109138/0001104659-20-109138-index.htm
2017-10-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417053252/0001144204-17-053252-index.htm
2017-10-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000114420417053253/0001144204-17-053253-index.htm
2017-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420417053990/0001144204-17-053990-index.htm
2017-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417057263/0001144204-17-057263-index.htm
2017-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420417058512/0001144204-17-058512-index.htm
2017-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417059277/0001144204-17-059277-index.htm
2017-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417061266/0001144204-17-061266-index.htm
2017-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417063248/0001144204-17-063248-index.htm
2017-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417064330/0001144204-17-064330-index.htm
2017-12-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417065088/0001144204-17-065088-index.htm
2018-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000266/0001144204-18-000266-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000853/0001144204-18-000853-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000854/0001144204-18-000854-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000856/0001144204-18-000856-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000857/0001144204-18-000857-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000859/0001144204-18-000859-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000860/0001144204-18-000860-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000861/0001144204-18-000861-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000862/0001144204-18-000862-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000863/0001144204-18-000863-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000864/0001144204-18-000864-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000865/0001144204-18-000865-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000868/0001144204-18-000868-index.htm
2018-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418005594/0001144204-18-005594-index.htm
2018-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418009043/0001144204-18-009043-index.htm
2018-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418014063/0001144204-18-014063-index.htm
2018-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418014635/0001144204-18-014635-index.htm
2018-03-2210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000114420418016468/0001144204-18-016468-index.htm
2018-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418022479/0001144204-18-022479-index.htm
2018-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418025173/0001144204-18-025173-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418027107/0001144204-18-027107-index.htm
2018-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420418027786/0001144204-18-027786-index.htm
2018-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418033770/0001144204-18-033770-index.htm
2018-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418039922/0001144204-18-039922-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418043267/0001144204-18-043267-index.htm
2018-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420418043686/0001144204-18-043686-index.htm
2018-10-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000114420418055035/0001144204-18-055035-index.htm
2018-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418056889/0001144204-18-056889-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418059340/0001144204-18-059340-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420418059980/0001144204-18-059980-index.htm
2018-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418066148/0001144204-18-066148-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419000167/0001144204-19-000167-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419002173/0001144204-19-002173-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419005129/0001144204-19-005129-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419016629/0001144204-19-016629-index.htm
2019-03-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000114420419016787/0001144204-19-016787-index.htm
2019-04-0110-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000114420419017194/0001144204-19-017194-index.htm
2019-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419020402/0001144204-19-020402-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419022029/0001144204-19-022029-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419025600/0001144204-19-025600-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419026041/0001144204-19-026041-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419029338/0001144204-19-029338-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419029669/0001144204-19-029669-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419031589/0001144204-19-031589-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419034627/0001144204-19-034627-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133869/000114420419034690/0001144204-19-034690-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419034770/0001144204-19-034770-index.htm
2019-07-17S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000114420419034954/0001144204-19-034954-index.htm
2019-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419035262/0001144204-19-035262-index.htm
2019-07-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419035263/0001144204-19-035263-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419037875/0001144204-19-037875-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419038387/0001144204-19-038387-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038994/0001144204-19-038994-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038995/0001144204-19-038995-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038996/0001144204-19-038996-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038997/0001144204-19-038997-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038998/0001144204-19-038998-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038999/0001144204-19-038999-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419039000/0001144204-19-039000-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419039001/0001144204-19-039001-index.htm
2019-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419040654/0001144204-19-040654-index.htm
2019-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419042160/0001144204-19-042160-index.htm
2019-08-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419042161/0001144204-19-042161-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419047446/0001144204-19-047446-index.htm
2019-07-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133869/999999999519001637/9999999995-19-001637-index.htm
2019-12-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133869/999999999519002841/9999999995-19-002841-index.htm
2020-05-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133869/999999999520001205/9999999995-20-001205-index.htm
2018-04-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1133869/999999999718004982/9999999997-18-004982-index.htm
2018-08-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1133869/999999999718007502/9999999997-18-007502-index.htm

Capricor Therapeutics, Inc (CAPR) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Capricor Therapeutics, Inc (CAPR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 253%
Institutional Ownership: 620%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2017-10-23Louis ManzoDirectorBuy20,748.000.163,319.68159,132.00https://www.sec.gov/Archives/edgar/data/1133869/000114420417053990/0001144204-17-053990-index.htm
2019-12-17Frank LitvackDirectorBuy20,391.0020,391.00https://www.sec.gov/Archives/edgar/data/1133869/000110465919074516/0001104659-19-074516-index.htm
2017-12-22Rachel SmithVice President of R&DBuy20,748.000.163,319.6820,748.00https://www.sec.gov/Archives/edgar/data/1133869/000114420418000868/0001144204-18-000868-index.htm
2019-12-17David B MusketDirectorBuy20,391.0022,891.00https://www.sec.gov/Archives/edgar/data/1133869/000110465919074514/0001104659-19-074514-index.htm
2019-12-17Louis ManzoDirectorBuy20,391.0036,304.00https://www.sec.gov/Archives/edgar/data/1133869/000110465919074513/0001104659-19-074513-index.htm
2020-09-24Louis ManzoDirectorBuy8,299.003.7030,706.3044,603.00https://www.sec.gov/Archives/edgar/data/1133869/000110465920109138/0001104659-20-109138-index.htm
2020-07-27Linda MarbanCHIEF EXECUTIVE OFFICERBuy41,497.003.70153,538.9062,367.00https://www.sec.gov/Archives/edgar/data/1133869/000110465920087909/0001104659-20-087909-index.htm